Contact Us
Drug Search Results
More Filters [+]

ZP-120

Alternative Names: zp-120, zp120, zp 120
Latest Update: 2022-07-01
Latest Update Note: PubMed Publication

Product Description

a novel ligand of the nociceptin/orphanin FQ (N/OFQ) peptide receptor, NOP. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/12237257/)

Mechanisms of Action: NOP Agonist

Novel Mechanism: Yes

Modality: Peptide/Protein

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Zealand Pharma
Company Location: COPENHAGEN G7 00000
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for ZP-120

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Heart Failure|Heart Failure, Acute|Heart Failure, Chronic

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2004-004801-11

P2

Active, not recruiting

Heart Failure, Chronic|Heart Failure, Acute

2005-06-18

NCT00283361

P2

Terminated

Heart Failure

None

Recent News Events

Date

Type

Title

07/01/2022

PubMed

 Supplementation With Zinc Proteinate Increases the Growth Performance by Reducing the Incidence of Diarrhea and Improving the Immune Function of Dairy Calves During the First Month of Life.

03/01/2020

PubMed

 Ser100-Phosphorylated RORα Orchestrates CAR and HNF4α to Form Active Chromatin Complex in Response to Phenobarbital to Regulate Induction of CYP2B6.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions